Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications assessment therapy changes drug discontinuation among crohns disease patients using
… if and why treatment responses vary over time and across disease subtypes. Or you can determine if your missing data … of results Support for scientific presentations and publications And each step will be delivered with the rigor … and observational studies , patient-centered outcomes assessment , and health preference assessment . Our …
… States. It allows Medicare to negotiate prescription drug prices with manufacturers and put an inflation cap on … will be chosen for the program. European Health Technology Assessment Regulation The European Regulation on Health … single arm, clinical trials. While preparation for the changes that JCAs and the IRA are bringing is applicable to …
… MSBase Registry: Comparing Natalizumab to Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple … cost-effectiveness of natalizumab as a disease-modifying therapy for relapsing-remitting MS, this research represents …
… be considered when evaluating PROs intended to support drug submissions as well as medical devices. The draft offers … feasible, rather than creating new measures. Concepts and changes in concepts measured by the PRO instrument should be … about the amount of change that is clinically meaningful. Assessment of a PRO instrument as “fit for purpose” is …
… Pooled Database Analysis Share on: November 27, 2023 For drug and biotech developers, understanding long-term … the long-term benefit of a treatment for kidney disease. Our client was developing a treatment that had been … on key influencing variables to control for differences among those variables Employed piecewise linear mixed models …
… may be used to demonstrate additional benefits to patients and provide compelling evidence for product … without symptoms or toxicity) is an approach that can help patients evaluate the trade-off between clinical benefit and … clinical and patient-centered outcomes Assessing burden of disease Exploring the impact of missing data We will …
… claims data, electronic medical records (EMRs), disease registries, and other health data sources—can help … your market and how to position your product for success. Using database studies, we can help you can gain insights on: … Behavioral Risk Factor Surveillance System (BRFSS) CPRD Drug Abuse Warning Network Friuli-Venezia-Giulia databases GE …
… is indicated in Europe to improve walking distances in patients with intermittent claudication. It has been … recommended risk-minimization measures, including labeling changes and communication to healthcare professionals. … Cilostazol's use was restricted to second-line therapy in case lifestyle modifications, including smoking …
… of high-dose versus standard-dose influenza vaccination in patients with end-stage renal disease Layton JB , McGrath LJ, Sahrmann JM, Ma Y, … Plotting daily incidence of influenza vaccine reactions among patients with end-stage renal disease to inform study …
… This hormonal excess results in tissue growth, including changes to facial features. As the condition progresses, many … on developing an Acromegaly Symptom Diary (ASD) to help patients with acromegaly capture their experiences with … outcomes (PROs) and are a major focus of ongoing drug development. The US Food and Drug Administration (FDA) …